Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Tokyo University of Science · National Center for Global Health and Medicine · +12 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
291
total citations
- FWCI
- 28.74
- Percentile
- 100%
- References
- 82
Citations per year
Authors
69- RURyuta UrakiCorresponding
Tokyo University of Science, National Center for Global Health and Medicine
- MKMaki Kiso
Tokyo University of Science
- SIShun Iida
National Institute of Infectious Diseases
- MIMasaki Imai
Tokyo University of Science, National Center for Global Health and Medicine
- ETEmi Takashita
National Institute of Infectious Diseases
Topics & keywords
Topics
Keywords
- Virology
- Infectivity
- Monoclonal antibody
- Biology
- Pathogenicity
- Lineage (genetic)
- Recombinant DNA
- Antibody
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- JAJapan Agency for Medical Research and DevelopmentAwards: JP20fk0108472, JP20fk0108502, JP21fk0108104, JP21fk0108615, 20HA2007, JP20nk0101632, JP22wm0125002, JP20fk0108412, HHSN272201400008C
- NCNational Center for Global Health and Medicine
- MModerna
- MOMinistry of Health, Labour and WelfareAwards: JP21fk0108615, JPMH20HA1006, 20HA2007
- SShionogi
- OPOtsuka Pharmaceutical
- NINational Institutes of HealthAwards: R01 AI157155, 75N93021C00014, 75N93019C00051, HHSN272201400008C
- NCNational Cancer InstituteAward: 75N93021C00014
- NINational Institute of Allergy and Infectious DiseasesAwards: HHSN272201400008C, R01 AI157155, 75N93019C00051, 75N93021C00014, AI157155
- DSDaiichi Sankyo Europe